245 related articles for article (PubMed ID: 26031919)
1. The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice.
Cui S; Lim KC; Shi L; Lee M; Jearawiriyapaisarn N; Myers G; Campbell A; Harro D; Iwase S; Trievel RC; Rivers A; DeSimone J; Lavelle D; Saunthararajah Y; Engel JD
Blood; 2015 Jul; 126(3):386-96. PubMed ID: 26031919
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons.
Rivers A; Vaitkus K; Jagadeeswaran R; Ruiz MA; Ibanez V; Ciceri F; Cavalcanti F; Molokie RE; Saunthararajah Y; Engel JD; DeSimone J; Lavelle D
Exp Hematol; 2018 Nov; 67():60-64.e2. PubMed ID: 30125603
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of long-term RN-1 treatment to increase HbF in baboons.
Ibanez V; Vaitkus K; Rivers A; Molokie R; Cui S; Engel JD; DeSimone J; Lavelle D
Blood; 2017 Jan; 129(2):260-263. PubMed ID: 27908882
[No Abstract] [Full Text] [Related]
4. RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model.
Rivers A; Vaitkus K; Ruiz MA; Ibanez V; Jagadeeswaran R; Kouznetsova T; DeSimone J; Lavelle D
Exp Hematol; 2015 Jul; 43(7):546-53.e1-3. PubMed ID: 25931013
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease.
Jagadeeswaran R; Vazquez BA; Thiruppathi M; Ganesh BB; Ibanez V; Cui S; Engel JD; Diamond AM; Molokie RE; DeSimone J; Lavelle D; Rivers A
Exp Hematol; 2017 Jun; 50():46-52. PubMed ID: 28238805
[TBL] [Abstract][Full Text] [Related]
6. Potential role of LSD1 inhibitors in the treatment of sickle cell disease: a review of preclinical animal model data.
Rivers A; Jagadeeswaran R; Lavelle D
Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R840-R847. PubMed ID: 30067082
[TBL] [Abstract][Full Text] [Related]
7. Effect of the LSD1 inhibitor RN-1 on γ-globin and global gene expression during erythroid differentiation in baboons (Papio anubis).
Ibanez V; Vaitkus K; Ruiz MA; Lei Z; Maienschein-Cline M; Arbieva Z; Lavelle D
PLoS One; 2023; 18(12):e0289860. PubMed ID: 38134183
[TBL] [Abstract][Full Text] [Related]
8. The LSD1 inhibitor RN-1 recapitulates the fetal pattern of hemoglobin synthesis in baboons (P. anubis).
Rivers A; Vaitkus K; Ibanez V; Ruiz MA; Jagadeeswaran R; Saunthararajah Y; Cui S; Engel JD; DeSimone J; Lavelle D
Haematologica; 2016 Jun; 101(6):688-97. PubMed ID: 26858356
[TBL] [Abstract][Full Text] [Related]
9. Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction.
Shi L; Cui S; Engel JD; Tanabe O
Nat Med; 2013 Mar; 19(3):291-4. PubMed ID: 23416702
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of LSD1 by small molecule inhibitors stimulates fetal hemoglobin synthesis.
Le CQ; Myers G; Habara A; Jearawiriyapaisarn N; Murphy GJ; Chui DHK; Steinberg MH; Engel JD; Cui S
Blood; 2019 May; 133(22):2455-2459. PubMed ID: 30992270
[No Abstract] [Full Text] [Related]
11. Combinatorial targeting of epigenome-modifying enzymes with decitabine and RN-1 synergistically increases HbF.
Ibanez V; Vaitkus K; Zhang X; Ramasamy J; Rivers AE; Saunthararajah Y; Molokie R; Lavelle D
Blood Adv; 2023 Aug; 7(15):3891-3902. PubMed ID: 36884303
[TBL] [Abstract][Full Text] [Related]
12. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
Zhang Y; Paikari A; Sumazin P; Ginter Summarell CC; Crosby JR; Boerwinkle E; Weiss MJ; Sheehan VA
Blood; 2018 Jul; 132(3):321-333. PubMed ID: 29884740
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease.
Krishnamoorthy S; Pace B; Gupta D; Sturtevant S; Li B; Makala L; Brittain J; Moore N; Vieira BF; Thullen T; Stone I; Li H; Hobbs WE; Light DR
JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046485
[TBL] [Abstract][Full Text] [Related]
14. Lysine-specific histone demethylase 1 inhibition enhances robust fetal hemoglobin induction in human β
Kaewsakulthong W; Pongpaksupasin P; Nualkaew T; Hongeng S; Fucharoen S; Jearawiriyapaisarn N; Sripichai O
Hematol Rep; 2021 Nov; 13(4):9215. PubMed ID: 35003571
[TBL] [Abstract][Full Text] [Related]
15. Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2.
Shearstone JR; Golonzhka O; Chonkar A; Tamang D; van Duzer JH; Jones SS; Jarpe MB
PLoS One; 2016; 11(4):e0153767. PubMed ID: 27073918
[TBL] [Abstract][Full Text] [Related]
16. MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease.
Li B; Zhu X; Ward CM; Starlard-Davenport A; Takezaki M; Berry A; Ward A; Wilder C; Neunert C; Kutlar A; Pace BS
Exp Hematol; 2019 Feb; 70():85-96.e5. PubMed ID: 30412705
[TBL] [Abstract][Full Text] [Related]
17. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
Hebert N; Rakotoson MG; Bodivit G; Audureau E; Bencheikh L; Kiger L; Oubaya N; Pakdaman S; Sakka M; Di Liberto G; Chadebech P; Vingert B; Pirenne F; Galactéros F; Cambot M; Bartolucci P
Am J Hematol; 2020 Nov; 95(11):1235-1245. PubMed ID: 32681733
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin increases fetal hemoglobin and ameliorates the nociception phenotype in sickle cell mice.
Khaibullina A; Almeida LE; Wang L; Kamimura S; Wong EC; Nouraie M; Maric I; Albani S; Finkel J; Quezado ZM
Blood Cells Mol Dis; 2015 Dec; 55(4):363-72. PubMed ID: 26460261
[TBL] [Abstract][Full Text] [Related]
19. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy.
Borba R; Lima CS; Grotto HZ
J Clin Lab Anal; 2003; 17(2):66-72. PubMed ID: 12640630
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA29B induces fetal hemoglobin
Gu Q; Palani CD; Smith A; Li B; Amos-Abanyie EK; Ogu U; Lu L; Pace BS; Starlard-Davenport A
Front Med (Lausanne); 2022; 9():1043686. PubMed ID: 36507536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
